health careNews

Global Biomarker Technologies Market is Growing at a highest CAGR of 13.8% Size and Analysis by leading Players with its Application and Type by 2025 with top key players: Thermo Fisher Scientific, Bio-Rad Laboratories, Healthcare, Agilent Technologies, Shimadzu Corporation, Waters Corporation,

Global Biomarker Technologies Market

The Global Biomarker Technologies Market is expected to reach USD 89.47 billion by 2025,growing at a CAGR of 13.8% during the forecast period of 2018 to 2025.

Market Definition:

Biomarkers which is also known as molecular marker or signature molecule, is used to check that how body responds to a treatment of any condition or disease. In simple words, they are used to examine the organ functions and other health conditions. It is also used in the imaging technology so that they can provide clear imaging of oncology tumors and other problems. They are also used in clinical studies to determine the effect and results of drugs in early stage.

Major Key players profiled in this report are:

Bio-Rad Laboratories, Agilent Technologies, SHIMADZU CORPORATION, Thermo Fisher Scientific, Waters Corporation, Roche, QIAGEN, Illumina, GE, Abbott, BD, Danaher Corporation, bioMérieux, Merck, Abbott, Myriad Genetics, Sysmex Corporation, Quest Diagnostics and others.

Get a Free Sample Copy of This Report now at:

Reasons to Purchase this Report

  • Current and future of global biomarker technologies market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Market Segmentation

Based on test type

  • solid biopsy and
  • liquid biopsy

On the basis of product

  • consumables,
  • instruments,
  • services and
  • software/informatics

On the basis of profiling technology

  • immunoassay,
  • PCR,
  • imaging technologies,
  • mass spectrometry,
  • NGS,
  • chromatography,
  • cytogenetics and other profiling technologies

The biomarker identification, validation & development research are further segmented on the basis of products into consumables, instruments, services and software. The routine biomarker-based tests are also further segmented on the basis of products into consumables, instruments, services and software.

On the basis of application

  • biomarker identification,
  • validation & development research and
  • routine biomarker-based tests

On the basis of research area

  • genomics,
  • proteomics,
  • metabolomics and other research areas

The metabolomics market segment is further sub segmented into metabolic flux, lipidomics and others.

Based on geography

  • North America & South America,
  • Europe,
  • Asia-Pacific and,
  • Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Get TOC for Full Analysis of Report at:

Market Overview:

This report gives market segmentation by technology, applications and five major geographical regions. This report also covers all the regions and countries of the world, which shows a regional development status, including market size. The data mentioned in the report helps the consumer to know about the competitors better.  The qualitative research conducted in this report provides outlook covering primary Data, Survey, scope of the product and vendor briefing. The market dynamic forces have been determined after conducting a detailed study of market.

Key Developments in the Market

Recently a microfluidic capillary immunoassay platform for fast and highly sensitive measurement of biomarkers has been developed by the Bioanalytical Microsystems Laboratory at IMTEK (Institute of Microsystem Technology). This micro-ELISA system combines microfluidic capillary channel (immobilization cell) where the primary antibodies are coated covalently with an electrochemical detection system.

Major market drivers and restraints

  • Increasing diagnostic applications of biomarkers
  • Increasing R&D funding for pharma and biotech companies
  • Increasing number of CROs and low cost of clinical trials in developing countries
  • High prevalence of cancer
  • High capital investments and low cost-benefit ratio
  • Poorly suited regulatory and reimbursement systems
  • Technical issues related to sample collection and storage

Competitive Analysis

The global biomarker technologies market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biomarker technologies market for global, Europe, North America, Asia Pacific and South America.

For More Details You Can Enquire Here at:

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Sopan gedam

Data Bridge Market Research

Tel: +1-888-387-2818



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *